Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL798138 | 1.00 | ALDH1A1 (0.37) | ALDH1A1HPGDMAPTNPC1RAB9A | |
| SCHEMBL29473063 | 0.94 | CA1 (0.34) | ALDH1A1HPGDMAPTNPC1RAB9A | |
| SCHEMBL11895979 | 0.94 | CA1 (0.34) | ALDH1A1HPGDMAPTNPC1RAB9A | |
| SCHEMBL29616890 | 0.93 | CA1 (0.40) | ALDH1A1HPGDMAPTNPC1RAB9A | |
| SCHEMBL26607 | 0.91 | CA1 (0.41) | ALDH1A1HPGDMAPTNPC1RAB9A | |
| SCHEMBL29349873 | 0.91 | CA1 (0.41) | ALDH1A1HPGDMAPTNPC1RAB9A | |
| SCHEMBL6165769 | 0.90 | APEX1 (0.38) | ALDH1A1HPGDMAPTNPC1RAB9A | |
| SCHEMBL9240542 | 0.90 | APEX1 (0.38) | ALDH1A1HPGDMAPTNPC1RAB9A | |
| SCHEMBL30491175 | 0.90 | APEX1 (0.38) | ALDH1A1HPGDMAPTNPC1RAB9A | |
| Phosphine SCHEMBL7943984 | 0.90 | CA1 (0.40) | ALDH1A1HPGDMAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4460538-B1 | ONE-COMPONENT EXPANDABLE THERMOSETTING EPOXY COMPOSITION WITH IMPROVED STORAGE STABILITY | SIKA TECH AG (CH) | 2026-02-11 | — | — | EP | claimed |
| EP-2459575-B2 | HYDROLYTICALLY STABLE PHOSPHITE COMPOSITIONS | ADDIVANT SWITZERLAND GMBH (CH) | 2018-07-25 | — | — | EP | claimed |
| EP-2459574-B1 | SOLID ALKYLARYL PHOSPHITE COMPOSITIONS AND METHODS FOR MANUFACTURING SAME | ADDIVANT SWITZERLAND GMBH (CH) | 2018-06-20 | — | — | EP | claimed |
| EP-3330343-A1 | PHOSPHITE ESTER COMPOSITION | Sumitomo Chemical Company, Ltd. (JP) | 2018-06-06 | — | — | EP | claimed |
| EP-2491078-B1 | POLYMERS WITH LOW GEL CONTENT AND ENHANCED GAS-FADING | ADDIVANT SWITZERLAND GMBH (CH) | 2016-09-28 | — | — | EP | claimed |
| EP-2459575-B1 | HYDROLYTICALLY STABLE PHOSPHITE COMPOSITIONS | ADDIVANT SWITZERLAND GMBH (CH) | 2014-12-17 | — | — | EP | claimed |
| EP-2057222-B1 | LIQUID PHOSPHITE BLENDS AS STABILIZERS | ADDIVANT SWITZERLAND GMBH (CH) | 2014-03-12 | — | — | EP | claimed |
| US-8309635-B2 | Solid alkylaryl phosphite compositions and methods for manufacturing same | CHEMTURA CORPORATION (US) | 2012-11-13 | — | — | US | claimed |
| EP-2880092-B1 | PHOSPHITE COMPOSITIONS | SI GROUP SWITZERLAND CHAA GMBH (CH) | 2020-09-30 | — | — | EP | disclosed |
| EP-3344693-A1 | COMPOSITION | Addivant Switzerland GmbH (CH) | 2018-07-11 | — | — | EP | disclosed |
| EP-3330343-A1 | PHOSPHITE ESTER COMPOSITION | Sumitomo Chemical Company, Ltd. (JP) | 2018-06-06 | — | — | EP | disclosed |
| US-20170260363-A1 | USE OF ORGANIC OXYIMIDES AS RADICAL GENERATORS IN PLASTICS, METHOD FOR GENERATING RADICALS IN PLASTICS AND USE OF SAID METHOD | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2017-09-14 | — | — | US | disclosed |
| US-20170260363-A1 | USE OF ORGANIC OXYIMIDES AS RADICAL GENERATORS IN PLASTICS, METHOD FOR GENERATING RADICALS IN PLASTICS AND USE OF SAID METHOD | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2017-09-14 | — | — | US | disclosed |
| WO-2017037205-A1 | COMPOSITION | ADDIVANT SWITZERLAND GMBH (CH) | 2017-03-09 | — | — | WO | disclosed |
| US-8916065-B2 | Phosphite compositions | ADDIVANT SWITZERLAND GMBH (CH) | 2014-12-23 | — | — | US | disclosed |
| US-20140045981-A1 | PHOSPHITE COMPOSITIONS | SI GROUP, INC. | 2014-02-13 | — | — | US | disclosed |
| WO-2014020170-A1 | PHOSPHITE COMPOSITIONS | ADDIVANT SWITZERLAND GMBH (CH) | 2014-02-06 | — | — | WO | disclosed |
| EP-2616473-A2 | PHOSPHORUS-CONTAINING MIXTURES, PROCESSES FOR PREPARING THEM AND USE THEREOF | Clariant Finance (BV) Limited (VG) | 2013-07-24 | — | — | EP | disclosed |
| US-20130172457-A1 | Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-07-04 | — | — | US | disclosed |
| WO-2012034680-A2 | PHOSPHORUS-CONTAINING MIXTURES, PROCESSES FOR PREPARING THEM AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172457-A1 | Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof | C9, PHOSPHO1, C5 | ALDH1A1 3188/4885HPGD 2441/4885MAPT 4374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.